Then, we detected Fas and IL-9 expression in CD4+ T cells from tumor tissues in a cohort of 36 cancer patients with non-small-cell lung carcinoma (NSCLC) (Supplementary Table 1). This evidence concerns the gene FAS and non-small cell lung carcinoma.